Table: Shin Nippon Biomedical - 6-MTH group results

Shin Nippon Biomedical Laboratories

02/11/2021 06:00

Nov 2 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2021        Sep 30, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             7.96                7.00             17.40    
                 (+13.7 pct)         (+9.6 pct)       (+15.2 pct) 
  Operating         1.97                1.16              3.80    
                 (+69.6 pct)         (+7.7 pct)       (+50.2 pct) 
  Recurring         2.53                1.31              4.60    
                 (+93.8 pct)         (+3.7 pct)       (+26.2 pct) 
  Net               3.50                1.14              4.90    
                (+207.5 pct)         (+29.9 pct)      (+33.8 pct) 
  EPS             84.15 yen           27.36 yen       117.69 yen  
  Ann Div                             20.00 yen        20.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             20.00 yen        20.00 yen  
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T